Strategic Acquisitions Drive Growth
Q & M Dental Group Ltd has announced significant expansion plans through two major acquisitions that will substantially increase its regional footprint. The Singapore-based dental services provider is acquiring a 100% stake in Australia’s Experteeth Dental Group and a 51% stake in Thailand’s Deezy Dental Home for approximately S$107 million and S$39 million respectively.
Company Profile
Q & M Dental Group operates as a comprehensive dental services provider across the Asia-Pacific region. The company has established itself as a regional healthcare player in the healthcare sector, focusing on dental care services and clinic operations across multiple markets.
Acquisition Details and Financing Structure
The combined S$146 million purchase will be financed through S$92 million in cash and the issuance of 86.7 million new shares, representing 9.1% of existing shares. The new shares are priced at S$0.70 each and will be subject to a 15-year moratorium, ensuring long-term commitment from the vendors.
The Australian acquisition targets Experteeth Dental Group, founded in 2017, which operates 40 dental clinics with 117 dentists across New South Wales, Victoria, Queensland, Tasmania, and the Australian Capital Territory. The group operates under multiple established brands including Elevate Dental Group, Lumiere Dental Group, Ace Dental Group, Yiruda Dental Group, Prestige Dental Group, and Bubble Teeth Dental Group.
The Thai acquisition involves Deezy Dental Home, also founded in 2017, which operates three dental clinics with 41 dentists.
Strong Financial Backing and Growth Prospects
The acquisitions are valued at an attractive price-to-earnings ratio of 11.4 times, with the Australian operation at 10 times and the Thai operation at 16 times. Importantly, the total S$146 million investment is supported by robust profit guarantees totalling S$126 million over six to eight years. This arrangement implies earnings growth of approximately 13%, with Thailand showing the highest growth potential at 22% compound annual growth rate.
Analyst Outlook
Phillip Securities Research maintains a positive outlook on these acquisitions, projecting that they could increase FY26 earnings per share by 1.04 cents, representing a 54% increase to 2.96 cents, excluding intangible amortisation. The research house maintains its BUY recommendation with an unchanged target price of S$0.71, based on price-to-earnings ratio of 25 times for FY26, aligned with Singapore’s healthcare sector valuation.
Frequently Asked Questions
Q: What companies is Q & M Dental acquiring and at what cost?
A: Q & M Dental is acquiring 100% of Australia's Experteeth Dental Group for S$107 million and 51% of Thailand's Deezy Dental Home for S$39 million, totalling acquisition value of S$146 million.
Q: How will the acquisitions be financed?
A: The purchase will be satisfied through S$92 million in cash and 86.7 million new shares worth S$54 million, issued at S$0.70 per share under a 15-year moratorium.
Q: What is the scale of the acquired operations?
A: The Australian group operates 40 dental clinics with 117 dentists across multiple states, whilst the Thai operation runs three clinics with 41 dentists.
Q: Are there profit guarantees backing these acquisitions?
A: Yes, the acquisitions are backed by six to eight-year profit guarantees totalling S$126 million, implying 13% earnings growth overall and 22% compound annual growth rate for Thailand.
Q: What is the valuation multiple for these acquisitions?
A: The combined acquisition is valued at price-to-earnings ratio of 11.4 times, with Australia at 10 times and Thailand at 16 times.
Q: What is the analyst's recommendation and target price?
A: Phillip Securities Research maintains a BUY recommendation with an unchanged target price of S$0.71, based on price-to-earnings ratio of 25 times for FY26.
Q: How will these acquisitions impact earnings?
A: The acquisitions are projected to increase FY26 earnings per share by 1.04 cents, representing a 54% increase to 2.96 cents, excluding intangible amortisation.
This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.
Disclaimer
These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products.
Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance.
Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries.
The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries.
Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned.
This advertisement has not been reviewed by the Monetary Authority of Singapore.
